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This study examined the effect of delphinidin on high glucose-induced cell proliferation and collagen
synthesis in mesangial cells. Glucose dose-dependently (5.6e25 mM) increased cell proliferation and
collagen I and IV mRNA levels, whereas pretreatment with delphinidin (50 mM) prevented cell prolif-
eration and the increased collagen mRNA levels induced by high glucose (25 mM). High glucose
increased reactive oxygen species (ROS) generation, and this was suppressed by pretreating delphinidin
or the antioxidant N-acetyl cysteine. NADPH oxidase (NOX) 1 was upregulated by high glucose, but
pretreatment with delphinidin abrogated this upregulation. Increased mitochondrial superoxide by
25 mM glucose was also suppressed by delphinidin. The NOX inhibitor apocynin and mitochondria-
targeted antioxidant Mito TEMPO inhibited ROS generation and cell proliferation induced by high
glucose. Phosphorylation of extracellular signal regulated kinase (ERK)1/2 was increased by high glucose,
which was suppressed by delphinidin, apocynin or Mito TEMPO. Furthermore, PD98059 (an ERK1/2
inhibitor) prevented the high glucose-induced cell proliferation and increased collagen mRNA levels.
Transforming growth factor (TGF)-b protein levels were elevated by high glucose, and pretreatment with
delphinidin or PD98059 prevented this augmentation. These results suggest that delphinidin prevents
high glucose-induced cell proliferation and collagen synthesis by inhibition of NOX-1 and mitochondrial
superoxide in mesangial cells.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Diabetic nephropathy (DN) is one of most common complica-
tions of diabetes and a leading cause of end stage renal diseases. DN
is characterized by an expansion of glomerular mesangium, which
was caused by mesangial cell proliferation and excessive accumu-
lation of extracellular matrix (ECM) (1,2). Although many clinical
factors, such as hypertension and hyperlipidemia, affect the
development of DN, hyperglycemia plays a major role in the
pathological process of DN (2e4). One of the mechanisms wherebylogy, College of Medicine,
Daegu 42415, South Korea.
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).hyperglycemia induces DN is by increasing the generation of
reactive oxygen species (ROS) (4) and clinical and animal studies
have shown increases in the production of ROS and in the markers
of oxidative stress in diabetic kidneys (5,6). Furthermore, the
scavenging of ROS suppresses hyperglycemia-induced cell prolif-
eration in mesangial cells (4).
Anthocyanins are abundant natural polyphenolics that
contribute the intense colors of fruits and vegetables, including
berries, red grapes, and red cabbage (7). Epidemiological studies
have shown anthocyanins protect against the developments of
cardiovascular diseases, cancer, and other chronic diseases, such as
osteoporosis (8,9). Furthermore, it has been shown that anthocy-
anins exert beneﬁcial effects on chronic diseases by reducing
oxidative stress and inﬂammation (9). Delphinidin is a represen-
tative anthocyanidin (aglycon of anthocyanin), and was reported to
exert the strongest anti-cancer effect among the commonnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243236anthocyanidins (8,9). Delphinidin has also been shown to have
antioxidant effects in the presence of oxidized low density lipo-
protein (ox-LDL) (10), ultraviolet B (11), and carbon tetrachloride
(12) in cells and mice. Moreover, among the common six antho-
cyanidins, delphinidin exerts the strongest antioxidant effects
against 2,2-diphenyl-1-picrylhydrazyl (9). Nevertheless, the effect
of delphinidin on high glucose-induced oxidative stress has not
been previously investigated. Therefore, in the present study, we
examined the effect of delphinidin on high glucose-induced cell
proliferation and collagen synthesis in mesangial cells, and subse-
quently explored themechanisms underlying the antioxidant effect
of delphinidin.
2. Material and methods
2.1. Reagents
Delphinidin, cyanidin, malvidin, Mito TEMPO, L-NIL, allopurinol,
N-acetyl-L-cysteine (NAC), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), bromodeoxyuridine (BrdU),
and 20,70-dichlorodihydroﬂuorescein diacetate (H2DCFH-DA) were
obtained from SigmaeAldrich (St Louis, MO, USA). MitoSOX Red
was obtained from Invitrogen (Carlsbad, CA, USA). Antibodies
against phosphorylated ERK and total ERK were purchased from
Cell Signaling Technology (Danvers, MA, USA), the TGF-b antibody
was from Abcam (Cambridge, UK).
2.2. Cell culture
Mouse mesangial cells (CRL-1927, ATCC, Manassas, VA, USA)
were cultured in Dulbecco's modiﬁed Eagle's medium supple-
mented with 10% fetal bovine serum (GIBCO, Carlsbad, NY, USA)
and 1% penicillin-streptomycin (GIBCO). High glucose treatmentFig. 1. Effects of glucose on cell proliferation and collagen synthesis in mouse mesangi
proliferation was measured using a MTT assay (A) and a BrdU assay (B). The mRNA expres
reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose 5.6 m
Osmotic control (OC). #p<0.05 vs. 10 and 17 mM glucose.was performed by culturing cells in DMEM containing 25 mM
(4500 mg/L) glucose for the indicated times and mannitol was used
to enhance osmotic pressure.
2.3. Cell proliferation assay
Cell proliferation was determined using a MTT assay or by
detecting BrdU incorporation using a commercial kit (Millipore,
Billerica, MA, USA) according to manufacturer's instructions.
Brieﬂy, cells were seeded in the wells of a 24-well plate containing
250 mL of growth medium, and 25 mL MTT stock solution was then
added to each well. After incubation for 4 h, dimethyl sulfoxide
solution was added to lyse cells and dissolve the formazan crystals
formed. After 5 min, 100 mL aliquots of the lysis solutions were
transferred to the wells of a 96-well plate, and absorbance was read
on a micro plate reader at 550 nm. For BrdU incorporation, cells
were seeded in the wells of a 96-well plate and then treated with
BrdU for 24 h. BrdU incorporation was detected using anti-BrdU
antibody and a peroxidase substrate and absorbance was read at
450 nm.
2.4. ROS generation
Intracellular ormitochondrial ROS levels weremeasured by ﬂow
cytometry. Mesangial cells were seeded in a 6-well plate at a
density of 2 105 cells per well. After synchronization for 24 h, cells
were pretreated with various agents for 1 h and then stimulated
with 25 mM glucose for 24 h. For intracellular ROS, H2DCF-DA was
added to each well at a ﬁnal concentration of 20 mM and incubated
for 20 min at 37 C in the dark. For mitochondrial superoxide, 5 mM
MitoSOX Redwas added to eachwell. The platewas washed 3 times
with PBS, and attached cells were trypsinized, re-suspended, and
then immediately subjected to FACSCalibur ﬂow cytometry (BDal cells. Cells were treated with glucose for 24 h in a dose dependent manner and cell
sion of collagen-I (C) and collagen-IV (D) were assessed by real-time PCR. Results are
mol/L þ mannitol 19.4 mmol/L) was used to enhance osmotic pressure. *p < 0.05 vs.
Fig. 2. Effects of delphinidin on high glucose-induced cell proliferation and collagen synthesis in mouse mesangial cells. Cells were pretreated with various doses (5e100 mM)
of delphinidin (Del) for 1 h and then treated with 25 mM glucose for 24 h. Cell proliferation was measured using a MTT assay (A). Cells were pretreated with 50 mM Del for 1 h prior
to 25 mM glucose exposure for 24 h and cell proliferation was measured using a MTT assay (B) and a BrdU assay (C). The mRNA expression of collagen-I (D) and collagen-IV (E) were
assessed by real-time PCR. Results are reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose 5.6 mmol/L þ mannitol 19.4 mmol/L) was used to
enhance osmotic pressure. *p < 0.05 vs. Osmotic control (OC). #p < 0.05 vs. 25 mM glucose.
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243 237Bioscience, San Jose, CA, USA). ROS were detected using excitation
and emission wavelengths of 514 nm and 529 nm, respectively for
H2DCF-DA and 510 nm and 580 nm, respectively for MitoSOX Red.
Cells treated with 1 mM hydrogen peroxide (H2O2) for 1 h were
used as a positive control.
2.5. Real-time polymerase chain reaction (RT-PCR)
Total RNA from cells was isolated using Trizol reagent (Sigma-
eAldrich), as directed by the manufacturer. To prepare cDNA, 1 mg
of each total RNA sample was reverse-transcribed using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, USA). Quantitative real-time PCR was performed
using Real-Time PCR 7500 System and Power SYBR Green PCR
master mix (Applied Biosystems), according to the manufacturer's
instructions. RT-PCRwas performed using the following conditions.Reactions were initiated at 95 C for 10 min, and this was followed
by 45 ampliﬁcation cycles of denaturation at 95 C for 15 s,
annealing at 55 C for 20 s, and hybridization-elongation at 72 C
for 35 s. Primers for b-actin, collagen-I and collagen-IV were based
on NCBI's Nucleotide database and designed using the Primer Ex-
press program (Applied Biosystems): b-actin (forward, 50-TGG ACA
GTG AGG CAA GGA TAG-30; reverse, 50-TAC TGC CCT GGC TCC TAG
CA-30), collagen-I (forward, 50-ACA TGC TCA GCT TTG TGG AT-30;
reverse, 50-ATA TTG GCA TGT TGC TAG GC-30), collagen-IV (forward,
50-GGG TCC TGT CTG CTG GAA GAG TTT AGA-30; reverse, 50-GCC
GTG GCA CTC GAT GA-30).
2.6. Western blot analysis
Mesangial cells were lysed and centrifuged at 700 g for 5 min.
Protein concentrations in the supernatants were determined using
Fig. 3. Effect of delphinidin, cyanidin, and malvidin on high glucose-induced reactive oxygen species generation (ROS) in mouse mesangial cells. Cells were pretreated with
50 mM of delphinidin (Del) or 1 mM N-acetyl cysteine (NAC) for 1 h and then exposed to 25 mM glucose for 24 h (A). Cells were pretreated with 50 mM of Del, cyanidin (Cyan), or
malvidin (Mal) for 1 h prior to 25 mM glucose exposure for 24 h (B and C). ROS levels were detected using a 20 ,70-dichloroﬂuorescein diacetate probe by ﬂow cytometry and cell
proliferation were measured using a MTT assay. Results are reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose 5.6 mmol/L þmannitol 19.4 mmol/
L) was used to enhance osmotic pressure. *p < 0.05 vs. Osmotic control (OC). #p < 0.05 vs. 25 mM glucose.
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243238the Bradford assay (SigmaeAldrich). Equal amounts of proteins
were separated by 12% Sodium Dodecyl Sulfate (SDS)-poly-
acrylamide gel electrophoresis at 80 V, and then transferred to a
0.45 mm polyvinylidenediﬂuoride (Millipore). After destaining,
membranes were blocked with 5% nonfat dry milk in TBST (10 mM
TriseHCl, pH 7.4/150 mM NaCl/0.1% Tween 20) and incubated
overnight at 4 C with primary antibodies (diluted 1:1000). Mem-
branes were washed in TBST and incubated with a goat-anti-rabbit
IgG secondary antibody (diluted 1:1000; Bio Rad, Hercules, CA,
USA) for 1 h at room temperature. Blots were detected using
a chemiluminescence reagent (Millipore).2.7. Statistical analysis
Results are expressed as mean ± SEM. The differences among
the groups were analyzed by one-way ANOVA followed by Tukey's
post hoc test. Statistical signiﬁcance was accepted for p
value < 0.05.3. Results
3.1. Delphinidin prevented glucose-induced cell proliferation and
collagen synthesis
Glucose treatment at 5.6, 10, 17, and 25 mM for 24 h increased
cell numbers in a dose dependent manner, and cell numbers at
25 mM glucose were higher than at 17 mM (Fig. 1A and B).
Furthermore, treatment with glucose for 24 h also dose depen-
dently increased the mRNA levels of collagen I and IV and the
mRNA levels at 25 mM glucose were signiﬁcantly higher than those
of osmotic control (Fig.1C and D). These results suggest that glucoseat 25 mM increases the cell proliferation and collagen synthesis in
mesangial cells.
The pretreatment of cells with delphinidin suppressed high
glucose-induced cell proliferation in a dose dependentmanner, and
50 mM delphinidin completely normalized the cell proliferation
(Fig. 2A). Delphinidin at a concentration of 50 mM was used in this
experiment since it was the lowest dose to completely suppress
high glucose-induced cell proliferation. Delphinidin alone had no
effect on cell proliferation (Fig. 2B and C). The high glucose (25 mM
glucose) also increased the mRNA levels of collagen I and IV, and
this was suppressed by delphinidin (Fig. 2D and E). These results
indicate that delphinidin inhibits cell proliferation and collagen
synthesis induced by high glucose concentrations.
3.2. Delphinidin suppressed high glucose-induced ROS generation
Treatment of cells with 25 mM glucose for 24 h increased ROS
generation, and pretreatment with 50 mM delphinidin or 1 mM N-
acetyl cysteine (NAC) suppressed the ROS generation (Fig. 3A).
While pretreatment of cells with 50 mM delphinidin completely
suppressed high glucose-induced ROS generation, cyanidin and
malvidin at 50 mM partially suppressed the ROS generation
(Fig. 3B). Cell proliferation showed similar results with ROS gen-
eration. While increased cell proliferation by high glucose was
normalized by delphinidin, cyanidin and malvidin partially sup-
pressed the cell proliferation (Fig. 3C). These results suggest that
delphinidin exhibits more potent antioxidant effect than cyanidin
and malvidin.
Next, we explored the speciﬁc targets of delphinidin among the
cellular sources of ROS generation. Increases in NOX-1 mRNA levels
by 25 mM glucose were suppressed by delphinidin pretreatment
(Fig. 4A). Pretreatment of apocynin (100 mM), NOX inhibitor,
Fig. 4. Effect of delphinidin on high glucose-induced NADPH oxidase activation and mitochondrial superoxide generation in mouse mesangial cells. Cells were pretreated
with 50 mM delphinidin (Del) for 1 h prior to 25 mM glucose exposure for 24 h. The mRNA level of NADPH oxidase 1 (NOX-1) was measured with real-time PCR (A). Cells were
pretreated with 100 mM apocynin (APO) for 1 h and then incubated in the presence of 25 mM glucose for 24 h. H2O2 (1 mM) was treated for 1 h as positive control (B). Cells were
pretreated with APO for 1 h in a dose dependent manner and then treated with 25 mM glucose for 24 h (C). Cells were pretreated with 50 mM Del for 1 h and then treated with
25 mM glucose for 24 h (D). Cells were pretreated with various doses (10e30 mM) of Mito TEMPO for 1 h prior to 25 mM glucose exposure for 24 h (E and F). Cells were pretreated
with various doses of inducible nitric oxide synthase inhibitor L-NIL (0.1e1 mM; G) or xanthine oxidase inhibitor allopurinol (1e30 mM; H) for 1 h and then treated with 25 mM
glucose for 24 h. Reactive oxygen species (ROS) levels were detected using 20 ,70-dichloroﬂuorescein diacetate probe and mitochondrial (Mito) superoxide levels were detected using
MitoSOX Red by ﬂow cytometry. Cell proliferation was measured using a MTT assay. Results are reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose
5.6 mmol/L þ mannitol 19.4 mmol/L) was used to enhance osmotic pressure. *p < 0.05 vs. Osmotic control (OC). #p < 0.05 vs. 25 mM glucose.
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Fig. 5. Effect of delphinidin on high glucose-induced ERK activation in mouse mesangial cells. Cells were treated with 25 mM glucose for 0, 5, 15, 30, and 60 min (A). Cells were
pretreated with the 50 mM delphinidin (Del; B), 1 mM N-acetyl-L-cysteine (NAC; C), 100 mM apocynin (Apo; D), or 30 mM Mito TEMPO (Mito; E) for 1 h and then incubated in the
presence of 25 mM glucose for 60 min. ERK phosphorylationwas measured with western blotting (AeE). Cells were pretreated with ERK inhibitor PD98059 (10 mM) for 1 h and then
exposed to 25 mM glucose for 24 h (FeH). Cell proliferation was measured using a MTT and the mRNA expression of collagen-I and collagen-IV was assessed by real-time PCR.
Results are reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose 5.6 mmol/L þ mannitol 19.4 mmol/L) was used to enhance osmotic pressure.
*p < 0.05 vs. Osmotic control (OC). #p < 0.05 vs. 25 mM glucose.
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Fig. 6. Effect of delphinidin on high glucose-induced TGF-b activation in mouse mesangial cells. Cells were treated with 25 mM glucose for 12 h or 24 h (A), pretreated with
50 mM delphinidin (Del) for 1 h and then treated with 25 mM glucose for 24 h (B), or pretreated with the ERK inhibitor PD98059 (10 mM) for 1 h and then treated with 25 mM
glucose for 24 h (C). Protein levels of TGF-b were measured by western blotting. Results are reported as the means ± SE of three to ﬁve separate experiments. Mannitol (glucose
5.6 mmol/L þ mannitol 19.4 mmol/L) was used to enhanc osmotic pressure. *p < 0.05 vs. Osmotic control (OC). #p < 0.05 vs. 25 mM glucose.
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243 241suppressed ROS generation (Fig. 4B), and does-dependently sup-
pressed glucose-induced cell proliferation (Fig. 4C). Increases in
mitochondrial superoxide levels by 25 mM glucose were also
suppressed by delphinidin pretreatment (Fig. 4D). Pretreatment of
cells with mitochondria-targeted antioxidant Mito TEMPO sup-
pressed high glucose-induced superoxide generation in mito-
chondria and cell proliferation in a dose dependent manner (Fig. 4E
and F). However, iNOS inhibitor L-NIL and xanthine oxidase in-
hibitor allopurinol had no effect on high glucose-induced ROS
generation (Fig. 4G and H). These results suggest that delphinidin
exhibits antioxidant effect through inhibition of NOX-1 activation
and mitochondrial superoxide generation in high glucose-treated
cells.3.3. Delphinidin suppressed high glucose-induced ERK1/2
activation and TGF-b expression
Treatment of mesangial cells with 25 mM glucose time-
dependently increased ERK1/2 phosphorylation, and signiﬁcantly
increased ERK1/2 phosphorylation after 60min of treatment versus
the osmotic control (Fig. 5A). Increased ERK phosphorylation by
25 mM glucose at 60 min was suppressed by delphinidin (50 mM)
pretreatment. Delphinidin alone had no effect on ERK phosphory-
lation (Fig. 5B). Furthermore, the increased ERK phosphorylationinduced by 25 mM glucose was inhibited by 1 mM NAC pretreat-
ment or 100 mM apocynin (Fig. 5C and D). Mito TEMPO at 30 mM
also suppressed high glucose-induced ERK activation (Fig. 5E). In
addition, increased cell numbers by 25mM glucose was suppressed
by pretreatment of ERK inhibitor PD98059 (10 mM). Increased
mRNA levels of collagen I and IV by 25 mM glucose was also sup-
pressed by PD98059 (Fig. 5FeH).
Treatment of cells with 25 mM glucose for 24 h increased the
protein levels of TGF-b at 24 h and this was suppressed by pre-
treatment of 50 mMdelphinidin, although delphinidin alone had no
effect on TGF-b protein levels (Fig. 6A and B). Increased TGF-b
protein levels induced by high glucose were inhibited by PD98059
(Fig. 6C). These results suggest that high glucose activates ERK1/2
and TGF-b, and thus, induces cell proliferation and collagen syn-
thesis, and these adverse effects of glucose are suppressed by
delphinidin.4. Discussion
The present study demonstrates delphinidin prevents high
glucose-induced cell proliferation and collagen synthesis in
mesangial cells, and these anti-proliferative and anti-ﬁbrotic effects
of delphinidin are mediated by suppressing NOX-1 activation,
mitochondrial superoxide generation, ERK1/2, and TGF-b. Thus,
High glucose
TGF-βMesangial cell 
proliferation
ERK1/2
Delphinidin
NADPH oxidase 1/mitochondria
ROS
Collagen synthesis
Fig. 7. Schematic diagram of a proposed pathway for the delphinidin-mediated
inhibition of high glucose-induced cell proliferation and collagen synthesis in
mesangial cells. High glucose induces cell proliferation and collagen synthesis in
mesangial cells by increasing reactive oxygen species (ROS). ERK1/2 and TGF-b are key
mediators of ROS-induced adverse effects and contributes to high glucose-induced cell
proliferation and collagen synthesis. However, delphinidin inhibits glucose-induced
cell proliferation and collagen synthesis by suppressing the NADPH oxidase 1 and
mitochondrial superoxide. ERK; extracellular signal-regulated kinase, ROS; reactive
oxygen species, TGF; transforming growth factor.
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243242this study elucidates the anti-oxidant effects of delphinidin in the
presence of high glucose in mesangial cells and the mechanism
responsible.
Hyperglycemia increases oxidative stress in peripheral tissues,
and oxidative stress is closely associated with hyperglycemia-
induced ﬁbrosis in human and animal studies (13,14). High
glucose also induces cell proliferation and collagen synthesis in
mesangial cells in vitro, and increased ROS generation is respon-
sible for the high glucose-induced effects (15). In the present study,
high glucose was found to increase cell proliferation and collagen
synthesis, and these effects were suppressed by the antioxidant
NAC, which suggests ROS is an important mediator of glucose-
induced mesangial cell activation. Like NAC, delphinidin also
inhibited high glucose-induced ROS generation, and suppressed
collagen synthesis and cell proliferation, which suggests that del-
phinidin counteracts the oxidant effect of high glucose. The anti-
oxidant effect of delphinidin was more potent than two common
anthocyanidins, cyanidin and malvidin, in this study and these
result are consistent with previous study (9). When compared with
resveratrol, ROS scavenging effect of delphinidin is more potent or
delphinidin exhibits a comparable potency depending on cells and
ROS inducers (16,17).ROS generation in cells occurs with mitochondria, peroxisomes,
plasma membrane NADPH oxidase (NOX), and other cellular ele-
ments (18). Among the sources of ROS, high glucose-induced
enhanced ROS generation is primarily mediated by mitochondria
and NOX (19). Mitochondrial ROS generation is enhanced in the
kidney of diabetic subjects (20) and mitochondrial targeted anti-
oxidant treatment prevents kidney damage in type 1 diabetic mice
model (21). NOX has also been reported as important source of ROS
generation in the podocytes (22) andmesangial cells (23). Moreover,
NOX is a main contributor of increased ROS generation in the
glomeruli of diabetic rats (24). The present study demonstrates that
delphinidin suppressed increases in NOX-1 mRNA levels and mito-
chondrial ROS generation induced by high glucose. These results
suggest that delphinidin counteracts the oxidant effect of glucose by
suppressing NOX-1, which is consistent with the ﬁnding of previous
studies that delphinidin suppresses NOX1 activation by ultraviolet B
and ox-LDL (25). Furthermore, although cyanidin is known to inhibit
glutamate-induced neuronal cell death through suppression of
mitochondrial ROS (26), this study is ﬁrstly showing that delphini-
din also suppresses mitochondrial ROS generation by high glucose.
Although the antioxidant effect of anthocyanin has received
considerable attention, it has not been examined extensively in the
context of high glucose. A chokeberry anthocyanin fraction sup-
presses high glucose-induced oxidative stress in pancreatic beta-
cells (27), and cynidin-3-glucoside, a common anthocyanin, pro-
tects hepatocytes from high glucose-induced apoptosis and ROS
generation (28,29). The present study is the ﬁrst to report that
delphinidin also suppresses high glucose-induced ROS generation
inmesangial cells. This result is consistent with previously reported
ﬁndings that delphinidin exhibits antioxidant effects against
physical and chemical factors. In particular, delphinidin exhibits
antioxidant effect in human immortalized HaCaT keratinocytes and
primary human umbilical vein endothelial cells and in animal tis-
sues, such as, liver and skin in mice, exposed to ultraviolet B, ox-
LDL, and carbon tetrachloride (10e12).
ERK1/2 is activated by oxidative stress in a variety of cell types,
including mesangial cells (30,31). Although ERK1/2 activation plays
a protective role in many cases against oxidative stress-induced cell
damage, ERK signaling pathways also mediate oxidative stress-
induced adverse responses, such as, collagen synthesis and extra-
cellular matrix accumulation (32,33). High glucose also activates
ERK1/2, which has been associated with increased ﬁbronectin and
collagen IV levels in primary cultured rat mesangial cells (34).
Furthermore, it has been shown that attenuation of oxidative stress
suppresses high glucose-induced ERK1/2 activation, and thereby
reduces cell proliferation and ﬁbrosis (35). In the present study,
high-glucose-induced ERK1/2 activation was inhibited by the an-
tioxidants, such as, NAC, apocynin, Mito TEMPO, and delphinidin,
and these results suggest ERK1/2 was stimulated by ROS. In addi-
tion, inhibition of high glucose-induced cell proliferation and
collagen synthesis by PD98059 indicates that ERK1/2mediates high
glucose-induced mesangial expansion. Moreover, inhibition of
ERK1/2 by apocynin or Mito TEMPO suggests that ROS stimulates
ERK1/2 phosphorylation. NOX- or mitochondrial ROS-induced
ERK1/2 activation has been reported previously (36,37).
TGF-b constitutes an important signaling pathway for extra-
cellular matrix accumulation and ﬁbrosis (38). Diabetic rats and
cells treated with high glucose levels demonstrate high levels of
collagen synthesis and TGF-b activation, and inhibition of TGF-b
attenuates the extracellular matrix accumulation (34). Consistent
with this previous study, we also observed that increased TGF-b
levels in high glucose-treated cells and it appears that TGF-b is a
mediator of glucose-induced collagen synthesis. This notion is
supported by our ﬁndings that delphinidin suppressed increase of
TGF-b levels as well as collagen synthesis in high glucose-treated
S.E. Song et al. / Journal of Pharmacological Sciences 130 (2016) 235e243 243mesangial cells. Furthermore, it seems that ERK1/2 activation is
responsible for the increase in TGF-b protein levels observed in the
present study, because pretreatment with PD98059 prevented
glucose-induced TGF-b increases. Consistent with our data,
PD98059 suppresses increased TGF-b mRNA levels and promotor
activity induced by high glucose in mesangial cells (39).
Based on our ﬁndings and previously reported data, we postu-
late high glucose enhances the release of ROS from activated NOX-1
and mitochondria, which activates ERK1/2 and TGF-b, and thereby,
mesangial cell proliferation and extracellular matrix accumulation.
Delphinidin blocks the glucose-induced NOX-1 activation and
mitochondrial superoxide generation, and thereby collagen syn-
thesis and matrix accumulation (Fig. 7). Delphinidin may be a po-
tential therapeutic treatment for diabetic nephropathy.Conﬂict of interest
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